Quick Answer
Eton Pharmaceuticals, Inc. reported Shares Outstanding of 27.05 million shares for fiscal year 2025.
Eton Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 27.05M | +1.3% |
| 2024 | 26.71M | +4.0% |
| 2023 | 25.69M | +1.3% |
| 2022 | 25.35M | +3.0% |
| 2021 | 24.63M | +1.3% |
| 2020 | 24.31M | +36.0% |
| 2019 | 17.88M | +1.5% |
| 2018 | 17.61M | +193.5% |
| 2017 | 6.00M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 26.82M | +3.8% | +0.0% |
| June 30, 2025 | 26.82M | +4.2% | +0.0% |
| March 31, 2025 | 26.82M | +4.4% | +0.4% |
| December 31, 2024 | 26.71M | +4.0% | +3.4% |
| September 30, 2024 | 25.84M | +0.7% | +0.4% |
| June 30, 2024 | 25.75M | +0.7% | +0.2% |
| March 31, 2024 | 25.69M | +0.7% | +0.0% |
| December 31, 2023 | 25.69M | +1.3% | +0.1% |
- Eton Pharmaceuticals, Inc. showed an increase of +1.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2017–2025 period, Eton Pharmaceuticals, Inc.’s shares outstanding has grown by 350.8% (from 6.00 million shares to 27.05 million shares).
- The most recent figure is from Eton Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: